Pablo Rojo Conejo

12PUBLICATIONS

45CO-AUTHORS

Disease surveillanceMajor global burdens of diseaseAdolescent healthInfant and child healthGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 03, 2026

Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

|Apr 12, 2026

Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.

James Wyncoll, Rujirek Kamolrattana, Moherndran Archary

|Feb 24, 2026

SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

Carlos Grasa, Nicolas Salvadori, Alessandra Nardone

|Sep 18, 2025

Preseptal and Orbital Cellulitis in Children.

Valeria Rubinacci, Lara López Rodríguez, Anna Jiménez

|Feb 05, 2025

Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.

Nomonde Bengu, Gabriela Cromhout, Emily Adland

|Jun 06, 2024

Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.

Nomonde Bengu, Gabriela Cromhout, Emily Adland

Pageof 2

Frequent Collaborators

Paolo Palma

Nicholas Herbert

Maria C Puertas

Christina Ochsenbauer

2 joint publications

Giuseppe Rubens Pascucci

Krista Dong

Gabriela Cromhout

Andreas Groll

Julia Roider

Alessandra Ruggiero

Frequent Collaborators

Paolo Palma

Nicholas Herbert

Maria C Puertas

Christina Ochsenbauer